WA
IDXX icon

Wambolt & Associates’s Idexx Laboratories IDXX Stock Holding History

Wambolt & Associates’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$231K Buy
+425
New +$203K 0.08% 168
2024
Q4 		– Sell
-442
Closed -$219K – 192
2024
Q3 		$219K Buy
442
+21
+5% +$10.2K 0.06% 189
2024
Q2 		$201K Buy
+421
New +$211K 0.06% 199

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wambolt & Associates's IDXX Position: Q2 2025 in Review

Wambolt & Associates opened a new position in Idexx Laboratories (IDXX) in Q2 2025: 425 shares worth $231K. The stake represents 0.08% of the portfolio and ranks #168 among its holdings. This is a return to the name: Wambolt & Associates previously reported a position in IDXX as recently as Q3 2024.

Wambolt & Associates first reported a position in IDXX in Q2 2024 and has held it in 3 quarters since. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Wambolt & Associates held 425 shares of Idexx Laboratories worth $231K as of Q2 2025.
  • Idexx Laboratories was a new Wambolt & Associates position in Q2 2025.
  • Idexx Laboratories made up 0.08% of Wambolt & Associates's portfolio in Q2 2025, its #168 holding.
  • Wambolt & Associates first reported a position in Idexx Laboratories in Q2 2024 and has held it in 3 quarters since.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Wambolt & Associates's 13F filing for Q2 2025, filed 13 Aug 2025.